These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

598 related items for PubMed ID: 24030729

  • 1. FLT3-ITD and MLL-PTD influence the expression of MDR-1, MRP-1, and BCRP mRNA but not LRP mRNA assessed with RQ-PCR method in adult acute myeloid leukemia.
    Nasilowska-Adamska B, Solarska I, Paluszewska M, Malinowska I, Jedrzejczak WW, Warzocha K.
    Ann Hematol; 2014 Apr; 93(4):577-93. PubMed ID: 24030729
    [Abstract] [Full Text] [Related]

  • 2. BCRP mRNA and FLT3-ITD are independent poor risk factors in adult patients with acute myeloid leukemia and intermediate or normal karyotype.
    Nasiłowska-Adamska B, Warzocha K, Solarska I, Borg K, Pieńkowska-Grela B, Czyż A.
    Eur J Haematol; 2017 Sep; 99(3):255-261. PubMed ID: 28618074
    [Abstract] [Full Text] [Related]

  • 3. Comparative analysis of MLL partial tandem duplication and FLT3 internal tandem duplication mutations in 956 adult patients with acute myeloid leukemia.
    Steudel C, Wermke M, Schaich M, Schäkel U, Illmer T, Ehninger G, Thiede C.
    Genes Chromosomes Cancer; 2003 Jul; 37(3):237-51. PubMed ID: 12759922
    [Abstract] [Full Text] [Related]

  • 4. Tandem duplications of MLL and FLT3 are correlated with poor prognoses in pediatric acute myeloid leukemia: a study of the Japanese childhood AML Cooperative Study Group.
    Shimada A, Taki T, Tabuchi K, Taketani T, Hanada R, Tawa A, Tsuchida M, Horibe K, Tsukimoto I, Hayashi Y.
    Pediatr Blood Cancer; 2008 Feb; 50(2):264-9. PubMed ID: 17763464
    [Abstract] [Full Text] [Related]

  • 5. Mll partial tandem duplication and Flt3 internal tandem duplication in a double knock-in mouse recapitulates features of counterpart human acute myeloid leukemias.
    Zorko NA, Bernot KM, Whitman SP, Siebenaler RF, Ahmed EH, Marcucci GG, Yanes DA, McConnell KK, Mao C, Kalu C, Zhang X, Jarjoura D, Dorrance AM, Heerema NA, Lee BH, Huang G, Marcucci G, Caligiuri MA.
    Blood; 2012 Aug 02; 120(5):1130-6. PubMed ID: 22674806
    [Abstract] [Full Text] [Related]

  • 6. Increased expression of lung resistance-related protein and multidrug resistance-associated protein messenger RNA in childhood acute lymphoblastic leukemia.
    Ogretmen B, Barredo JC, Safa AR.
    J Pediatr Hematol Oncol; 2000 Aug 02; 22(1):45-9. PubMed ID: 10695821
    [Abstract] [Full Text] [Related]

  • 7. Expression of multidrug resistance-related transporters in human breast carcinoma.
    Kanzaki A, Toi M, Nakayama K, Bando H, Mutoh M, Uchida T, Fukumoto M, Takebayashi Y.
    Jpn J Cancer Res; 2001 Apr 02; 92(4):452-8. PubMed ID: 11346468
    [Abstract] [Full Text] [Related]

  • 8. High frequency of additional gene mutations in acute myeloid leukemia with MLL partial tandem duplication: DNMT3A mutation is associated with poor prognosis.
    Kao HW, Liang DC, Kuo MC, Wu JH, Dunn P, Wang PN, Lin TL, Shih YS, Liang ST, Lin TH, Lai CY, Lin CH, Shih LY.
    Oncotarget; 2015 Oct 20; 6(32):33217-25. PubMed ID: 26375248
    [Abstract] [Full Text] [Related]

  • 9. Concomitant ABCG2 overexpression and FLT3-ITD mutation identify a subset of acute myeloid leukemia patients at high risk of relapse.
    Tiribelli M, Geromin A, Michelutti A, Cavallin M, Pianta A, Fabbro D, Russo D, Damante G, Fanin R, Damiani D.
    Cancer; 2011 May 15; 117(10):2156-62. PubMed ID: 21523728
    [Abstract] [Full Text] [Related]

  • 10. The roles of four multi-drug resistance proteins in hepatocellular carcinoma multidrug resistance.
    Li G, Chen X, Wang Q, Xu Z, Zhang W, Ye L.
    J Huazhong Univ Sci Technolog Med Sci; 2007 Apr 15; 27(2):173-5. PubMed ID: 17497289
    [Abstract] [Full Text] [Related]

  • 11. Synergism of Curcumin and Cytarabine in the Down Regulation of Multi-Drug Resistance Genes in Acute Myeloid Leukemia.
    Shah K, Mirza S, Desai U, Jain N, Rawal R.
    Anticancer Agents Med Chem; 2016 Apr 15; 16(1):128-35. PubMed ID: 26278546
    [Abstract] [Full Text] [Related]

  • 12. Relevance of two genes in the multidrug resistance of hepatocellular carcinoma: in vivo and clinical studies.
    Sun Z, Zhao Z, Li G, Dong S, Huang Z, Ye L, Liang H, Qu J, Ai X, Zhang W, Chen X.
    Tumori; 2010 Apr 15; 96(1):90-6. PubMed ID: 20437864
    [Abstract] [Full Text] [Related]

  • 13. Increased expression of the breast cancer resistance protein (BCRP) in relapsed or refractory acute myeloid leukemia (AML).
    van den Heuvel-Eibrink MM, Wiemer EA, Prins A, Meijerink JP, Vossebeld PJ, van der Holt B, Pieters R, Sonneveld P.
    Leukemia; 2002 May 15; 16(5):833-9. PubMed ID: 11986944
    [Abstract] [Full Text] [Related]

  • 14. [The clinical significance of lung resistance-related protein gene (lrp), multidrug resistance-associated protein gene (mrp) and mdr-1/p170 expression in acute leukemia].
    Zhao Y, Yu L, Lou F, Wang Q, Pu J, Zhou Q.
    Zhonghua Nei Ke Za Zhi; 1999 Nov 15; 38(11):760-3. PubMed ID: 11798719
    [Abstract] [Full Text] [Related]

  • 15. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
    Kuchenbauer F, Kern W, Schoch C, Kohlmann A, Hiddemann W, Haferlach T, Schnittger S.
    Haematologica; 2005 Dec 15; 90(12):1617-25. PubMed ID: 16330434
    [Abstract] [Full Text] [Related]

  • 16. Negative impact of FLT3-ITD mutation on expression of MDR-1 mRNA in adult acute myeloid leukemia.
    Nasiłowska-Adamska B, Solarska I.
    Leuk Lymphoma; 2012 Dec 15; 53(12):2523-6. PubMed ID: 22591177
    [No Abstract] [Full Text] [Related]

  • 17. Prognostic significance of multidrug resistance gene 1 (MDR1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) mRNA expression in acute leukemia.
    Huh HJ, Park CJ, Jang S, Seo EJ, Chi HS, Lee JH, Lee KH, Seo JJ, Moon HN, Ghim T.
    J Korean Med Sci; 2006 Apr 15; 21(2):253-8. PubMed ID: 16614510
    [Abstract] [Full Text] [Related]

  • 18. Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia.
    den Boer ML, Pieters R, Kazemier KM, Rottier MM, Zwaan CM, Kaspers GJ, Janka-Schaub G, Henze G, Creutzig U, Scheper RJ, Veerman AJ.
    Blood; 1998 Mar 15; 91(6):2092-8. PubMed ID: 9490695
    [Abstract] [Full Text] [Related]

  • 19. Multiple drug resistance protein (MDR-1), multidrug resistance-related protein (MRP) and lung resistance protein (LRP) gene expression in childhood acute lymphoblastic leukemia.
    Valera ET, Scrideli CA, Queiroz RG, Mori BM, Tone LG.
    Sao Paulo Med J; 2004 Jul 01; 122(4):166-71. PubMed ID: 15543372
    [Abstract] [Full Text] [Related]

  • 20. CD34-related coexpression of MDR1 and BCRP indicates a clinically resistant phenotype in patients with acute myeloid leukemia (AML) of older age.
    van den Heuvel-Eibrink MM, van der Holt B, Burnett AK, Knauf WU, Fey MF, Verhoef GE, Vellenga E, Ossenkoppele GJ, Löwenberg B, Sonneveld P.
    Ann Hematol; 2007 May 01; 86(5):329-37. PubMed ID: 17340137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 30.